PUBLIC CONTRACT · 2024
Aquisição de diversos medicamentos do AQ2023/491
- Contract value
- €109,833.00
- Signed on
- 7 November 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11040660PUBLISHED SUBJECT
Aquisição de BRODALUMAB 210 MG/1.5 ML SOL INJ SER 1.5 ML SC, CABAZITAXEL 10 MG/ML SOL INJ FR 6 ML IV e RITUXIMAB 120 MG/ML SOL INJ FR 11.7 ML SC
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- LEO FARMACEUTICOS , LDA · Tax ID 503932680
- Bidder
- BIOJAM SA Health Consulting · Tax ID 513642749
- Bidder
- SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
- Bidder
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
- Bidder
- ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Values and timeline
- Contract price
- €109,833.00
- Procedure base price
- €431,012.10
- Total effective price
- Not reported on Portal BASE
- Publication date
- 22 November 2024
- Award date
- 4 November 2024
- Signing date
- 7 November 2024
- Performance period
- 53 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7256141
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.